CompuGroup posts strong 2009 results

  • 16 February 2010

The health IT specialist says it expects to achieve revenues of between €315m and €330m for 2010, a projected 19% increase, and operating profit (EBITDA) between €67m and €73m in 2010.

"I am proud of the progress of our company and the performance of our employees," said Frank Gotthardt, CompuGroup’s founder and chief executive officer. "The progress we have made, in particular during the past two quarters, demonstrates that we are successfully managing and continuing our growth by focusing on our core business."

Gotthardt added that there remains big potential for efficiency savings in the health sector, underpinned by IT. "We are going on the assumption that ‘more health’ and ‘more efficiency’ can be achieved in this area with the use of our software solutions. These effects could be in the range of as much as 15% of all healthcare spending.”

CompuGroup has approximately 2,800 employees in 18 different countries, and develops intelligent software for private practice physicians, dentists, hospitals and consumers. In its home market the company says almost 50% of private practice physicians uses CompuGroup systems, with approximately 326,000 users worldwide.

 

Subscribe To Our Newsletters

Subscribe to our newsletter

Subscribe To Our Newsletter

Related News

North East and Yorkshire trusts adopt tech for faster scan results

North East and Yorkshire trusts adopt tech for faster scan results

NHS England is expanding the rollout of Hexarad to help patients in the North East and South Yorkshire receive hospital scan results faster.
Digital Health’s monthly roundup of contracts and go lives

Digital Health’s monthly roundup of contracts and go lives

Our latest roundup features Powys Teaching Health Board rolling out an electronic prescribing and medicines administration (ePMA) system.
NHS AI blood test could reduce invasive cancer exams for women

NHS AI blood test could reduce invasive cancer exams for women

Thousands of women could avoid invasive diagnostic procedures for suspected womb cancer under an NHS trial of an AI blood test.